Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2337/dc20-1295 http://scihub22266oqcxt.onion/10.2337/dc20-1295 32540920!7372044!32540920     free     free     free       Diabetes+Care 2020 ; 43 (8): 1690-1694 Nephropedia Template TP {{tp|p=32540920|t=2020. Diabetes Epidemiology in the COVID-19 Pandemic |pdf=|usr=}}{{32540920}} gab.com Text Diabetes Epidemiology in the COVID-19 Pandemic JO: Diabetes Care http://www.kidney.de/pget.php?&tw=1&pmid=32540920 #FOAvip Diabetes has been identified as an important risk factor for mortality and rates of progression to acute respiratory distress syndrome (ARDS) in hospitalized patients with coronavirus disease 2019 (COVID-19). However, many recent reports on this topic reflect hurried approaches and have lacked careful epidemiologic design, conduct, and analysis. Features of prior studies have posed problems for our understanding of the true contribution of diabetes and other underlying comorbidities to prognosis in COVID-19. In this Perspective, we discuss some of the challenges of interpreting the current literature on diabetes and COVID-19 and discuss opportunities for future epidemiologic studies. We contend that the COVID-19 pandemic is a defining moment for the field of epidemiology and that diabetes epidemiology should play a significant role. Twit Text FOAVip Diabetes Epidemiology in the COVID-19 Pandemic ????Diabetes Care http://www.kidney.de/pget.php?&tw=1&pmid=32540920 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32540920 #FOAvip English Wikipedia <ref>{{Cite pmid|32540920}}</ref> Diabetes Epidemiology in the COVID-19 Pandemic #MMPMID32540920 Selvin E; Juraschek SP Diabetes Care 2020[Aug]; 43 (8): 1690-1694 PMID32540920show ga Diabetes has been identified as an important risk factor for mortality and rates of progression to acute respiratory distress syndrome (ARDS) in hospitalized patients with coronavirus disease 2019 (COVID-19). However, many recent reports on this topic reflect hurried approaches and have lacked careful epidemiologic design, conduct, and analysis. Features of prior studies have posed problems for our understanding of the true contribution of diabetes and other underlying comorbidities to prognosis in COVID-19. In this Perspective, we discuss some of the challenges of interpreting the current literature on diabetes and COVID-19 and discuss opportunities for future epidemiologic studies. We contend that the COVID-19 pandemic is a defining moment for the field of epidemiology and that diabetes epidemiology should play a significant role. |*Betacoronavirus[MESH] |*Coronavirus Infections/epidemiology[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/epidemiology[MESH] |COVID-19[MESH] |Comorbidity[MESH] |Diabetes Mellitus/*epidemiology[MESH] |Humans[MESH] |Prognosis[MESH] |Risk Factors[MESH]Diabetes Epidemiology in the COVID-19 Pandemic (epmc).pdf DeepDyve Pubget Overpricing